BioArctic AB (publ)

OM:BIOA B Stock Report

Market Cap: SEK 15.0b

BioArctic Future Growth

Future criteria checks 6/6

BioArctic is forecast to grow earnings and revenue by 62.5% and 49.2% per annum respectively. EPS is expected to grow by 60.7% per annum. Return on equity is forecast to be 42.9% in 3 years.

Key information

62.5%

Earnings growth rate

60.7%

EPS growth rate

Biotechs earnings growth44.4%
Revenue growth rate49.2%
Future return on equity42.9%
Analyst coverage

Good

Last updated10 Dec 2024

Recent future growth updates

BioArctic AB (publ) (STO:BIOA B) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Sep 01
BioArctic AB (publ) (STO:BIOA B) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Recent updates

Need To Know: Analysts Are Much More Bullish On BioArctic AB (publ) (STO:BIOA B)

Nov 27
Need To Know: Analysts Are Much More Bullish On BioArctic AB (publ) (STO:BIOA B)

BioArctic AB (publ) (STO:BIOA B) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Sep 01
BioArctic AB (publ) (STO:BIOA B) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Need To Know: The Consensus Just Cut Its BioArctic AB (publ) (STO:BIOA B) Estimates For 2024

Aug 15
Need To Know: The Consensus Just Cut Its BioArctic AB (publ) (STO:BIOA B) Estimates For 2024

Revenues Tell The Story For BioArctic AB (publ) (STO:BIOA B)

Apr 13
Revenues Tell The Story For BioArctic AB (publ) (STO:BIOA B)

News Flash: 6 Analysts Think BioArctic AB (publ) (STO:BIOA B) Earnings Are Under Threat

Feb 19
News Flash: 6 Analysts Think BioArctic AB (publ) (STO:BIOA B) Earnings Are Under Threat

News Flash: 6 Analysts Think BioArctic AB (publ) (STO:BIOA B) Earnings Are Under Threat

Feb 03
News Flash: 6 Analysts Think BioArctic AB (publ) (STO:BIOA B) Earnings Are Under Threat

Investors Interested In BioArctic AB (publ)'s (STO:BIOA B) Revenues

Dec 23
Investors Interested In BioArctic AB (publ)'s (STO:BIOA B) Revenues

With EPS Growth And More, BioArctic (STO:BIOA B) Makes An Interesting Case

Nov 12
With EPS Growth And More, BioArctic (STO:BIOA B) Makes An Interesting Case

BioArctic AB (publ) (STO:BIOA B) Analysts Are Way More Bearish Than They Used To Be

Jul 21
BioArctic AB (publ) (STO:BIOA B) Analysts Are Way More Bearish Than They Used To Be

Analysts Have Lowered Expectations For BioArctic AB (publ) (STO:BIOA B) After Its Latest Results

Jul 15
Analysts Have Lowered Expectations For BioArctic AB (publ) (STO:BIOA B) After Its Latest Results

New Forecasts: Here's What Analysts Think The Future Holds For BioArctic AB (publ) (STO:BIOA B)

Jul 07
New Forecasts: Here's What Analysts Think The Future Holds For BioArctic AB (publ) (STO:BIOA B)

Things Look Grim For BioArctic AB (publ) (STO:BIOA B) After Today's Downgrade

May 06
Things Look Grim For BioArctic AB (publ) (STO:BIOA B) After Today's Downgrade

Companies Like BioArctic (STO:BIOA B) Can Afford To Invest In Growth

Mar 13
Companies Like BioArctic (STO:BIOA B) Can Afford To Invest In Growth

Broker Revenue Forecasts For BioArctic AB (publ) (STO:BIOA B) Are Surging Higher

Nov 30
Broker Revenue Forecasts For BioArctic AB (publ) (STO:BIOA B) Are Surging Higher

We're Not Worried About BioArctic's (STO:BIOA B) Cash Burn

Sep 16
We're Not Worried About BioArctic's (STO:BIOA B) Cash Burn

We're Interested To See How BioArctic (STO:BIOA B) Uses Its Cash Hoard To Grow

Apr 04
We're Interested To See How BioArctic (STO:BIOA B) Uses Its Cash Hoard To Grow

Earnings and Revenue Growth Forecasts

OM:BIOA B - Analysts future estimates and past financials data (SEK Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,7007595266386
12/31/20259732883263506
12/31/2024251-223-264-2486
9/30/2024167-233-171-163N/A
6/30/2024299-88-142-134N/A
3/31/2024252-122-111-104N/A
12/31/2023616229302310N/A
9/30/2023607259113126N/A
6/30/2023617270284289N/A
3/31/2023619327294307N/A
12/31/2022229-11-44-32N/A
9/30/202223228-15-13N/A
6/30/202218-147-170-159N/A
3/31/202221-135-147-143N/A
12/31/202126-120-145-140N/A
9/30/202130-114-138-128N/A
6/30/202137-97-114-103N/A
3/31/202134-101-106-93N/A
12/31/202065-69-105-92N/A
9/30/202084-72-125-120N/A
6/30/202093-60-163-160N/A
3/31/202025278-46-43N/A
12/31/201928388324327N/A
9/30/2019779441286292N/A
6/30/2019852475305310N/A
3/31/2019729380171176N/A
12/31/2018722382-204-200N/A
9/30/201825758-161-157N/A
6/30/201819732N/A-149N/A
3/31/201819429N/A-139N/A
12/31/201715715N/A-135N/A
9/30/201719378N/A616N/A
6/30/201716071N/A630N/A
3/31/201712764N/A647N/A
12/31/201610658N/A675N/A
12/31/2015424N/A-16N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: BIOA B is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.2%).

Earnings vs Market: BIOA B is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: BIOA B is expected to become profitable in the next 3 years.

Revenue vs Market: BIOA B's revenue (49.2% per year) is forecast to grow faster than the Swedish market (1.2% per year).

High Growth Revenue: BIOA B's revenue (49.2% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: BIOA B's Return on Equity is forecast to be very high in 3 years time (42.9%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 21:27
End of Day Share Price 2024/12/18 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BioArctic AB (publ) is covered by 7 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kristofer Liljeberg-SvenssonCarnegie Investment Bank AB
Patrik LingDNB Markets
Rajan SharmaGoldman Sachs